| Source Date | Board Meeting Date | Details |
| 05 Jun 2025 | 10 Jun 2025 | Inter alia, to consider and approve terms & conditions of the issuance of Non-Convertible Debentures on private placement basis. |
| 16 May 2025 | 21 May 2025 | The meeting of the Finance Committee is scheduled to be held on Wednesday, May 21, 2025, inter alia, to consider and approve terms & conditions of the issuance of Non- Convertible Debentures on private placement basis. |
| 02 May 2025 | 08 May 2025 | Audited Results |
| 10 Mar 2025 | 13 Mar 2025 | Inter alia, to consider and approve terms & conditions of the issuance of Non-Convertible Debentures on private placement basis. |
| 24 Feb 2025 | 28 Feb 2025 | Inter alia, to consider and approve fund raising through Issuance of Non-Convertible Debentures through private placement basis at the Finance Committee meeting of the Company. |
| 05 Feb 2025 | 12 Feb 2025 | Quarterly Results |
| 18 Dec 2024 | 23 Dec 2024 | Inter alia, to consider and approve:- 1. to convert the existing medium term note programme into a global medium term note programme ( GMTN ) of the Company in accordance with Regulation S and/or Rule 144A of the U.S. Securities Act, 1933, as applicable, and decide all matters in relation thereto; and 2. subject to the market conditions and regulatory compliances, issuance of secured debt instruments in the form of US Dollar / other foreign currency denominated notes under the GMTN programme. |
| 28 Oct 2024 | 31 Oct 2024 | Inter alia, to consider and approve the public issue of secured, rated, listed, redeemable non-convertible debentures, in one or more tranches, in compliance with the provisions of the Securities and Exchange Board of India (Issue and Listing of Non-Convertible Securities) Regulations, 2021, as amended, subject to regulatory and statutory approvals, as may be applicable. |
| 17 Oct 2024 | 23 Oct 2024 | Quarterly Results |
| 30 Jul 2024 | 06 Aug 2024 | Quarterly Results |
| 12 Jun 2024 | 15 Jun 2024 | Audited Results & Quarterly Results Inter alia, to consider and approve:- (b) Issuance of Non-Convertible Debentures, in one or more tranches on an annual basis through private placement; |
| 18 Apr 2024 | 17 Apr 2024 | Inter alia, to consider and approve (1) various matters in connection with the Rights Issue including the specific terms of the Rights Issue, such as the determination of the Rights Issue price and related payment mechanism, rights entitlement ratio, the record date and timing of the Rights Issue. (2) Any other transaction with the approval of the Chair. |
| 12 Apr 2024 | 17 Apr 2024 | Inter alia, to consider, approve various matters in connection with the Rights Issue including the specific terms of the Rights Issue, such as the determination of the Rights Issue price and related payment mechanism, rights entitlement ratio, the record date and timing of the Rights Issue. |
| 07 Mar 2024 | 13 Mar 2024 | Inter alia, to consider and approve:- The proposal for raising of funds by issuance of equity shares / convertible bonds / debentures / warrants / preference shares / any other equity linked securities (?Securities?) through permissible modes including by way of right issue, private placement, preferential issue or any other methods or modes as may be permitted under applicable laws, subject to such regulatory, statutory and shareholders? approval as may be required in this regard |
| 10 Jan 2024 | 17 Jan 2024 | Interim Dividend & Quarterly Results |
| 11 Oct 2023 | 18 Oct 2023 | Quarterly Results Inter-alia, to consider and approve a proposal to pass an enabling resolution in respect of the following matter, subject to shareholders? approval: ?To raise funds by issuance of equity shares / depository receipts / convertible bonds / debentures / warrants / preference shares / any other equity linked securities (?Securities?) through permissible modes including by way of a private placement, including through a preferential issue or qualified institutions placement of Securities or any other method or mode as may be permitted under applicable laws, subject to such regulatory/ statutory approvals as may be required.? |
| 20 Jul 2023 | 27 Jul 2023 | Quarterly Results |
| 17 Apr 2023 | 26 Apr 2023 | Audited Results Inter alia, to consider and approve:- 1) Issuance of Secured or Unsecured Redeemable Non-Convertible Debentures, in one or more tranches on an annual basis through private placement. |
| 23 Jan 2023 | 30 Jan 2023 | Interim Dividend & Quarterly Results |
| 17 Oct 2022 | 26 Oct 2022 | Quarterly Results |
